Logo image of MNDR

MOBILE-HEALTH NETWORK SOLUTI (MNDR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:MNDR - KYG622641259 - Common Stock

1.06 USD
-0.27 (-20.3%)
Last: 12/15/2025, 7:26:42 PM
1.04 USD
-0.02 (-1.89%)
After Hours: 12/15/2025, 7:26:42 PM
Fundamental Rating

2

Taking everything into account, MNDR scores 2 out of 10 in our fundamental rating. MNDR was compared to 100 industry peers in the Health Care Providers & Services industry. The financial health of MNDR is average, but there are quite some concerns on its profitability. MNDR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

MNDR had negative earnings in the past year.
In the past year MNDR has reported a negative cash flow from operations.
In the past 5 years MNDR reported 4 times negative net income.
MNDR had negative operating cash flow in 4 of the past 5 years.
MNDR Yearly Net Income VS EBIT VS OCF VS FCFMNDR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -113.31%, MNDR is doing worse than 96.00% of the companies in the same industry.
The Return On Equity of MNDR (-192.59%) is worse than 79.00% of its industry peers.
Industry RankSector Rank
ROA -113.31%
ROE -192.59%
ROIC N/A
ROA(3y)-121.89%
ROA(5y)-86.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNDR Yearly ROA, ROE, ROICMNDR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 200 -200 400 600 800

1.3 Margins

MNDR has a worse Gross Margin (16.06%) than 64.00% of its industry peers.
In the last couple of years the Gross Margin of MNDR has declined.
MNDR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.44%
GM growth 5YN/A
MNDR Yearly Profit, Operating, Gross MarginsMNDR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 -50 -100

More info and screens

5

2. Health

2.1 Basic Checks

MNDR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, MNDR has less shares outstanding
MNDR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MNDR Yearly Shares OutstandingMNDR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 5M 10M
MNDR Yearly Total Debt VS Total AssetsMNDR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -9.28, we must say that MNDR is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MNDR (-9.28) is worse than 93.00% of its industry peers.
MNDR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.28
ROIC/WACCN/A
WACC8.83%
MNDR Yearly LT Debt VS Equity VS FCFMNDR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M

2.3 Liquidity

A Current Ratio of 1.06 indicates that MNDR should not have too much problems paying its short term obligations.
MNDR has a worse Current ratio (1.06) than 67.00% of its industry peers.
MNDR has a Quick Ratio of 1.06. This is a bad value and indicates that MNDR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.99, MNDR is not doing good in the industry: 67.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.99
MNDR Yearly Current Assets VS Current LiabilitesMNDR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for MNDR have decreased strongly by -303.19% in the last year.
The Revenue for MNDR has decreased by -42.16% in the past year. This is quite bad
Measured over the past years, MNDR shows a small growth in Revenue. The Revenue has been growing by 3.04% on average per year.
EPS 1Y (TTM)-303.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325.52%
Revenue 1Y (TTM)-42.16%
Revenue growth 3Y3.04%
Revenue growth 5YN/A
Sales Q2Q%-45.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year76.44%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MNDR Yearly Revenue VS EstimatesMNDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
MNDR Yearly EPS VS EstimatesMNDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 -1 -2 -3 -4 -5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

MNDR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 51.96, the valuation of MNDR can be described as expensive.
MNDR's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of MNDR to the average of the S&P500 Index (23.78), we can say MNDR is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 51.96
MNDR Price Earnings VS Forward Price EarningsMNDR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNDR Per share dataMNDR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 -10 -15

4.3 Compensation for Growth

MNDR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNDR!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

MOBILE-HEALTH NETWORK SOLUTI

NASDAQ:MNDR (12/15/2025, 7:26:42 PM)

After market: 1.04 -0.02 (-1.89%)

1.06

-0.27 (-20.3%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-23 2024-10-23
Earnings (Next)N/A N/A
Inst Owners4.39%
Inst Owner Change-97.19%
Ins Owners12.22%
Ins Owner ChangeN/A
Market Cap1.94M
Revenue(TTM)11.92M
Net Income(TTM)-5.04M
Analysts82.86
Price TargetN/A
Short Float %9.66%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.96
P/S 0.16
P/FCF N/A
P/OCF N/A
P/B 0.74
P/tB 7.58
EV/EBITDA N/A
EPS(TTM)-19.48
EYN/A
EPS(NY)0.02
Fwd EY1.92%
FCF(TTM)-3.71
FCFYN/A
OCF(TTM)-2.38
OCFYN/A
SpS6.52
BVpS1.43
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -113.31%
ROE -192.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.06%
FCFM N/A
ROA(3y)-121.89%
ROA(5y)-86.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-15.44%
GM growth 5YN/A
F-Score4
Asset Turnover2.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1416.51%
Cap/Sales 20.44%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.99
Altman-Z -9.28
F-Score4
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)567.57%
Cap/Depr(5y)346.48%
Cap/Sales(3y)11.73%
Cap/Sales(5y)7.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-303.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-325.52%
EPS Next Y150%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-42.16%
Revenue growth 3Y3.04%
Revenue growth 5YN/A
Sales Q2Q%-45.26%
Revenue Next Year76.44%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y69.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year161.12%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.91%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y31.94%
OCF growth 3YN/A
OCF growth 5YN/A

MOBILE-HEALTH NETWORK SOLUTI / MNDR FAQ

What is the ChartMill fundamental rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MNDR.


What is the valuation status of MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

ChartMill assigns a valuation rating of 1 / 10 to MOBILE-HEALTH NETWORK SOLUTI (MNDR). This can be considered as Overvalued.


How profitable is MOBILE-HEALTH NETWORK SOLUTI (MNDR) stock?

MOBILE-HEALTH NETWORK SOLUTI (MNDR) has a profitability rating of 0 / 10.


Can you provide the financial health for MNDR stock?

The financial health rating of MOBILE-HEALTH NETWORK SOLUTI (MNDR) is 5 / 10.